Covered recipient · General Payments record
MICHELLE LEJEUNE WALTON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$857.75
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $792.27 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $214.49 | 10 |
| Insmed, Inc. | $132.91 | 5 |
| Shionogi Inc | $125.05 | 7 |
| Merck Sharp & Dohme Corporation | $122.35 | 5 |
| Theratechnologies Inc. | $119.50 | 3 |
| Melinta Therapeutics, Inc. | $40.14 | 2 |
| PFIZER INC. | $19.75 | 1 |
| La Jolla Pharmaceutical Company | $18.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.64 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376349 | CMS |
| ABBVIE INC. | $25.90 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376351 | CMS |
| ABBVIE INC. | $22.89 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376353 | CMS |
| ABBVIE INC. | $3.70 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376355 | CMS |
| ABBVIE INC. | $27.17 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376357 | CMS |
| ABBVIE INC. | $17.45 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376359 | CMS |
| ABBVIE INC. | $18.01 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376361 | CMS |
| ABBVIE INC. | $29.52 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376363 | CMS |
| ABBVIE INC. | $18.88 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376365 | CMS |
| ABBVIE INC. | $22.33 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108376367 | CMS |
| Insmed, Inc. | $27.73 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089580930 | CMS |
| Insmed, Inc. | $22.98 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089580494 | CMS |
| Insmed, Inc. | $23.44 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089581498 | CMS |
| Insmed, Inc. | $32.07 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089578522 | CMS |
| Insmed, Inc. | $26.69 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089573176 | CMS |
| La Jolla Pharmaceutical Company | $18.08 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154254207 | CMS |
| Melinta Therapeutics, LLC | $18.55 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140481888 | CMS |
| Melinta Therapeutics, LLC | $21.59 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140483244 | CMS |
| Merck Sharp & Dohme LLC | $14.97 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141872823 | CMS |
| Merck Sharp & Dohme LLC | $23.98 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141932951 | CMS |
| Merck Sharp & Dohme LLC | $29.22 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141712780 | CMS |
| Merck Sharp & Dohme LLC | $19.80 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141712778 | CMS |
| Merck Sharp & Dohme LLC | $34.38 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141712776 | CMS |
| PFIZER INC. | $19.75 | 10/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130960682 | CMS |
| Shionogi Inc | $24.75 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154340648 | CMS |
| Shionogi Inc | $15.05 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154340658 | CMS |
| Shionogi Inc | $19.51 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154340664 | CMS |
| Shionogi Inc | $17.45 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154340754 | CMS |
| Shionogi Inc | $14.96 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154340756 | CMS |
| Shionogi Inc | $16.52 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154340760 | CMS |
| Shionogi Inc | $16.81 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154340780 | CMS |
| Theratechnologies Inc. | $34.87 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092907176 | CMS |
| Theratechnologies Inc. | $43.47 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092907171 | CMS |
| Theratechnologies Inc. | $41.16 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092907180 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.